Efficacy News and Research

RSS

Current evidence on cannabis use in palliative care

Scientists from Wellington, New Zealand, have conducted a systematic review to understand the effectiveness of medicinal cannabis in palliative care settings.

13 Jun 2022

Stress accelerates aging of the immune system

Stress - in the form of traumatic events, job strain, everyday stressors and discrimination - accelerates aging of the immune system, potentially increasing a person's risk of cancer, cardiovascular disease and illness from infections such as COVID-19, according to a new USC study.

13 Jun 2022

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

A team of researchers from National University of Singapore, in collaboration with clinicians from the National University Cancer Institute, Singapore which is part of the National University Health System (NUHS), has reported promising results in using CURATE.AI, an artificial intelligence (AI) tool that identifies and better allows clinicians to make optimal and personalized doses of chemotherapy for patients.

13 Jun 2022

Smartwatches used to monitor short-term effects of 4th BNT162b2 booster shot

In a recent study posted to the medRxiv* pre-print server, researchers in Israel compared the short-term effects of the first and second booster doses of messenger ribonucleic acid (mRNA-based) coronavirus disease 2019 (COVID-19) vaccine BNT162b2.

13 Jun 2022

SARS-CoV-2 BA.4/5 variants escape vaccine and BA.1 infection induced antibodies

In a recent work published in the Cell journal, investigators examined the severe acute respiratory syndrome coronavirus (SARS-CoV-2) Omicron BA.5/4 variants escape from neutralizing antibodies induced by SARS-CoV-2 vaccines and natural infection.

13 Jun 2022

Fezolinetant reduces the frequency and severity of menopausal hot flashes, study finds

Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with menopause, according to a Phase 3 industry-sponsored study being presented Saturday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus intramuscular route in mice.

12 Jun 2022

Androgens contribute to sex bias in bladder cancer

Male sex hormones interfere with the body's ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.

10 Jun 2022

Study investigates SARS-CoV-2 escape from nirmatrelvir

Researchers assessed SARS-CoV-2 Alpha, Delta, and Omicron variants’ resistance to nirmatrelvir, a protease inhibitor of SARS-CoV-2.

10 Jun 2022

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Texas Medical Branch, Pfizer Vaccines Research & Development and BioNTech assessed the neutralization titers of sera from individuals vaccinated with the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine and previously infected with the Omicron sublineage BA.1.

10 Jun 2022

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

A recent research letter posted to the JAMA Network Open assessed the durability of immunity conferred by the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA)-1273 vaccine.

10 Jun 2022

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.

9 Jun 2022

The effectiveness of non-pharmacological treatments for post-viral syndromes and long COVID

A recent systematic review investigated the effectiveness of non-pharmacologic interventions for post-viral syndromes, including the post-COVID-19 syndrome.

9 Jun 2022

Stem cell models help determine previously unknown genetic markers of glaucoma

Stem cell models of the retina and optical nerve have been used to identify previously unknown genetic markers of glaucoma, in research jointly led by scientists from the Garvan Institute of Medical Research, the University of Melbourne, and the Centre for Eye Research Australia.

9 Jun 2022

Study confirms benefits and safety of goat milk-based infant formula

Researchers discuss the efficacy and safety of a goat milk-based formulation in infants.

8 Jun 2022

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

In a recent study published in the Lancet, researchers evaluated the safety and efficacy of tixagevimab–cilgavimab, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) combination in patients with mild to moderate coronavirus disease 2019 (COVID-19).

8 Jun 2022

Electronic nose detects SARS-CoV-2 from breath

Researchers discuss the development of an electronic nose device for the detection of SARS-CoV-2.

8 Jun 2022

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.

8 Jun 2022

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to be undertreated for several cardiovascular risk factors: hypertension (also called high blood pressure), diabetes and high cholesterol, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

8 Jun 2022

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Micronutrient deficiencies can promote inflammation and render the immune system particularly sensitive to allergenic substances.

8 Jun 2022

Efficacy News and Research

Current evidence on cannabis use in palliative care

Stress accelerates aging of the immune system

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

Smartwatches used to monitor short-term effects of 4th BNT162b2 booster shot

SARS-CoV-2 BA.4/5 variants escape vaccine and BA.1 infection induced antibodies

Fezolinetant reduces the frequency and severity of menopausal hot flashes, study finds

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

Androgens contribute to sex bias in bladder cancer

Study investigates SARS-CoV-2 escape from nirmatrelvir

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

The effectiveness of non-pharmacological treatments for post-viral syndromes and long COVID

Stem cell models help determine previously unknown genetic markers of glaucoma

Study confirms benefits and safety of goat milk-based infant formula

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

Electronic nose detects SARS-CoV-2 from breath

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News